当前位置:首页 - 行情中心 - 沃森生物(300142) - 财务分析 - 现金流量表

沃森生物

(300142)

  

流通市值:219.54亿  总市值:222.63亿
流通股本:15.77亿   总股本:15.99亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金441,691,381.882,608,820,008.551,771,029,1941,140,953,138.4
  收到的税费返还-6,958,581.516,947,105.181,631,558.23
  收到其他与经营活动有关的现金27,216,907.66173,137,841.9172,075,640.8651,084,430.8
  经营活动现金流入小计468,908,289.542,788,916,431.971,850,051,940.041,193,669,127.43
  购买商品、接受劳务支付的现金302,965,750.731,719,060,891.191,338,841,211.27778,736,131.3
  支付给职工以及为职工支付的现金124,192,531.74351,293,078.4272,877,806.58198,170,171.69
  支付的各项税费34,284,138.45138,407,899.7797,197,320.0256,667,782.43
  支付其他与经营活动有关的现金27,704,921.6689,228,396.4561,443,512.4143,437,957.66
  经营活动现金流出小计489,147,342.582,297,990,265.811,770,359,850.281,077,012,043.08
  经营活动产生的现金流量净额-20,239,053.04490,926,166.1679,692,089.76116,657,084.35
二、投资活动产生的现金流量:
  收回投资收到的现金6,661,283.13188,751,283.69158,285,591.07-
  取得投资收益收到的现金-3,444,383.943,444,383.94-
  处置固定资产、无形资产和其他长期资产收回的现金净额-699,903.18192,715191,389
  投资活动现金流入小计6,661,283.13192,895,570.81161,922,690.01191,389
  购建固定资产、无形资产和其他长期资产支付的现金94,889,103.18509,544,939.65357,253,150.1141,478,824.71
  投资支付的现金50,000,000---
  投资活动现金流出小计144,889,103.18509,544,939.65357,253,150.1141,478,824.71
  投资活动产生的现金流量净额-138,227,820.05-316,649,368.84-195,330,460.09-141,287,435.71
三、筹资活动产生的现金流量:
  吸收投资收到的现金-2,702,5002,440,0002,440,000
  其中:子公司吸收少数股东投资收到的现金-2,702,5002,440,0002,440,000
  取得借款收到的现金952,570,000159,000,000--
  收到其他与筹资活动有关的现金24,690,053.13144,098,105.75--
  筹资活动现金流入小计977,260,053.13305,800,605.752,440,0002,440,000
  偿还债务支付的现金-393,694,507.64232,993,145.4424,510,000
  分配股利、利润或偿付利息支付的现金54,459,702.96789,862,333.69788,889,566.3434,172,909.88
  其中:子公司支付给少数股东的股利、利润-760,868,500760,868,500409,731,500
  支付其他与筹资活动有关的现金1,145,806,224.041,706,427,438.87947,982,701.17745,691,685.76
  筹资活动现金流出小计1,200,265,9272,889,984,280.21,969,865,412.911,204,374,595.64
  筹资活动产生的现金流量净额-223,005,873.87-2,584,183,674.45-1,967,425,412.91-1,201,934,595.64
四、汇率变动对现金及现金等价物的影响-1,147,114.85-951,793.34908,358.771,233,445.54
五、现金及现金等价物净增加额-382,619,861.81-2,410,858,670.47-2,082,155,424.47-1,225,331,501.46
  加:期初现金及现金等价物余额1,348,244,145.543,759,102,816.013,759,102,816.013,759,102,816.01
  期末现金及现金等价物余额965,624,283.731,348,244,145.541,676,947,391.542,533,771,314.55
补充资料:
  净利润-125,157,091.43--7,094,241.99
  资产减值准备-251,664,603.63-192,719,154.7
  固定资产和投资性房地产折旧-261,911,123.09-131,884,394.83
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-261,911,123.09-131,884,394.83
  无形资产摊销-119,364,342.7-63,213,823.7
  长期待摊费用摊销-19,665,557.34-9,993,117.25
  处置固定资产、无形资产和其他长期资产的损失--81,071.48--130,387.03
  固定资产报废损失-1,011,398.04-602,963.92
  公允价值变动损失--29,676,000--13,422,300
  财务费用--20,919,436.84--8,569,362.17
  投资损失--2,554,430.79-486,057.34
  递延所得税--15,513,603.88--7,437,726.37
  其中:递延所得税资产减少--6,253,912.1-1,557,420.75
    递延所得税负债增加--9,259,691.78--8,995,147.12
  存货的减少-162,932,645.67-78,348,276.39
  经营性应收项目的减少-111,912,551.74--28,432,302.07
  经营性应付项目的增加--504,759,687.96--301,465,399.82
  现金的期末余额-1,348,244,145.54-2,533,771,314.55
  减:现金的期初余额-3,759,102,816.01-3,759,102,816.01
  现金及现金等价物的净增加额--2,410,858,670.47--1,225,331,501.46
公告日期2026-04-282026-03-282025-10-292025-08-26
审计意见(境内)标准无保留意见
TOP↑